Who is sponsoring NCT05369494?

NCT05369494 is sponsored by Abbott Nutrition.

What drugs are being tested in NCT05369494?

Interventions in NCT05369494: Hydrolyzed protein infant formula with oligosaccharides.

What condition does NCT05369494 study?

NCT05369494 studies Gastrointestinal Tolerance.

Is NCT05369494 still recruiting?

NCT05369494 is currently completed. Last updated 1 May 2024.

Last reviewed 2024-05-01 · How we verify

NCT05369494

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Infants Fed a Hydrolyzed Infant Formula

Completed NA Last updated 1 May 2024

What this trial tests

NA trial testing Hydrolyzed protein infant formula with oligosaccharides in Gastrointestinal Tolerance in 33 participants. Completed in 18 November 2023.

Timeline

7 May 2022

Primary endpoint
23 June 2023

18 November 2023

Quick facts

Lead sponsor	Abbott Nutrition
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	33
Start date	7 May 2022
Primary completion	23 June 2023
Estimated completion	18 November 2023
Sites	7 locations across United States

Drugs / interventions tested

Hydrolyzed protein infant formula with oligosaccharides

Conditions studied

Gastrointestinal Tolerance — all drugs for Gastrointestinal Tolerance →

Sponsor

Abbott Nutrition — full company profile →

Who can join

Adults 0 Days to 90 Days, any sex, with Gastrointestinal Tolerance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this non-randomized, multi-center study is to evaluate the growth, tolerance and compliance of an extensively hydrolyzed infant formula in an intended use population of infants.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Tolerance of Infants Fed a Hydrolyzed Rice Infant Formula with 2′-Fucosyllactose (2′-FL) Human Milk Oligosaccharide (HMO)
· 2024

Verify or expand the search:

Other Abbott Nutrition trials

Trials by the same sponsor.

NCT06709001 — An Observational Study to Assess Malnutrition Risk · completed
NCT06368765 — Oral Rehydration Solution and Dehydration Recovery · NA · terminated
NCT06205537 — Muscle Health and Recovery in Older Adults · NA · completed
NCT06130475 — Oral Rehydration Solution in Healthy Adults · NA · completed
NCT06266702 — Evaluation of a Nutritional Technology for Vitamin D Absorption · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05369494 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Abbott Nutrition
Last refreshed: 1 May 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05369494.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing